Adicet Bio (GB:0HX7)

Adicet Bio (0HX7) Stock Price & Analysis


0HX7 Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.88 - $21.20
Previous Close$5.88
Average Volume (3M)254.00
Market Cap
Enterprise Value$17.66M
Total Cash (Recent Filing)$257.66M
Total Debt (Recent Filing)$21.02M
Price to Earnings (P/E)N/A
May 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding19,589,828
10 Day Avg. Volume18
30 Day Avg. Volume254
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)0.93
Price to Sales (P/S)11.65
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-4.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.71
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.26
Price Target Upside349.06% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5




What was Adicet Bio’s price range in the past 12 months?
Adicet Bio lowest stock price was $5.88 and its highest was $21.20 in the past 12 months.
    What is Adicet Bio’s market cap?
    Currently, no data Available
    When is Adicet Bio’s upcoming earnings report date?
    Adicet Bio’s upcoming earnings report date is May 15, 2023 which is in 48 days.
      How were Adicet Bio’s earnings last quarter?
      Adicet Bio released its earnings results on Mar 15, 2023. The company reported -$0.72 earnings per share for the quarter, missing the consensus estimate of -$0.28 by -$0.44.
        Is Adicet Bio overvalued?
        According to Wall Street analysts Adicet Bio’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Adicet Bio pay dividends?
          Adicet Bio does not currently pay dividends.
          What is Adicet Bio’s EPS estimate?
          Adicet Bio’s EPS estimate is -$0.59.
            How many shares outstanding does Adicet Bio have?
            Currently, no data Available
            What happened to Adicet Bio’s price movement after its last earnings report?
            Adicet Bio reported an EPS of -$0.72 in its last earnings report, missing expectations of -$0.28. Following the earnings report the stock price went down -4.359%.
              Which hedge fund is a major shareholder of Adicet Bio?
              Among the largest hedge funds holding Adicet Bio’s share is RA Capital Management. It holds Adicet Bio’s shares valued at N/A.


                Adicet Bio Stock Smart Score

                The Adicet Bio Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Adicet Bio

                resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Seres Therapeutics
                IDEAYA Biosciences
                Gossamer Bio

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis